Live Breaking News & Updates on Trials program

Stay informed with the latest breaking news from Trials program on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Trials program and stay connected to the pulse of your community

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension ...

SOUTH SAN FRANCISCO, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced additional 48-week data from FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten

China , United-states , Fadyi-malik , Diane-weiser , Clinical-trials-program-for-aficamten , American-college-of-cardiology , Youtube , Corporate-affairs , Exchange-commission , Research-development , Linkedin , Facebook

Dr Merchán on the Role of Immunotherapy and TKI Combinations in RCC

Jaime R. Merchán, MD, discusses the current roles for immunotherapy and TKIs in patients with renal cell carcinoma.

Miami , Florida , United-states , Jaimer-merch , Department-of-medicine , Clinical-trials-program , Clinical-oncology-research-program , Sylvester-comprehensive-cancer-center , University-of-miami-miller-school-medicine , Division-of-medical-oncology , Trials-program

Dr Merchan on Key Data Supporting Pembrolizumab-Based Regimens in Advanced RCC

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.

Jaimer-merch , Division-of-medical-oncology , Department-of-medicine , Clinical-trials-program , University-of-miami-health-system , Sylvester-comprehensive-cancer-center , Clinical-oncology-research-program , Medical-oncology , Trials-program , Miami-health-system , Cancers-symposium

Non–Clear Cell RCC Subtypes Require Individualized Approach to Treatment Selection

Jaime R. Merchán, MD, spotlights case studies of patients with rare non-ccRCC histologies, discussing their clinical presentation, recent data on immunotherapy and targeted treatment options for the management of these disease subtypes, and patient outcomes on these therapies.

University-of-miami , Florida , United-states , Jaimer-merch , Department-of-medicine , National-cancer-institute , University-of-miami-health-system , National-comprehensive-cancer-network , Division-of-medical-oncology , Clinical-oncology-research-program , Science-summit

Frontline IO/TKI Regimens Continue to Evolve in ccRCC

Jaime R. Merchán, MD, discusses the evolution and current role of IO/TKI regimens in advanced RCC; highlights data from the phase 3 CLEAR and KEYNOTE-426 trials supporting the use of pembrolizumab-based regimens in untreated ccRCC; and speculates on how future biomarker-driven research could improve the benefit seen with these combinations in this disease.

Florida , United-states , University-of-miami , Jaimer-merch , Clinical-oncology-research-program , Division-of-medical-oncology , Department-of-medicine , University-of-miami-health-system , Science-summit , Medical-oncology , Trials-program

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Robert-perkins , Semin-nephrol , Twitter , National-institute-of-diabetes , Clinical-trials-program , American-society-of-nephrology , York-heart-association , American-kidney-fund , National-institutes-of-health , American-diabetes-association

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
valdostadailytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from valdostadailytimes.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Semin-nephrol , Robert-perkins , National-diabetes-statistics , American-association-of-clinical-endocrinology , Facebook , American-diabetes-association , Twitter , National-institute-of-diabetes , Centers-for-disease , National-institutes-of-health

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

WHIPPANY, N.J.--(BUSINESS WIRE)--Nov 2, 2023--

United-states , American , Semin-nephrol , Christian-rommel , American-kidney-fund , National-diabetes-statistics , Head-of-research , National-institute-of-diabetes , Facebook , American-diabetes-association , Bayer-healthcare-pharmaceuticals-inc , Twitter

Bayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology

Bayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Bayer-kerendia , Robert-perkins , Theresaa-mcdonagh , Nikolaus-marx , Semin-nephrol , National-institutes-of-health , Heart-failure-association , Clinical-trials-program , Bayer-healthcare-pharmaceuticals-inc , York-heart-association

Bayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology | Business

WHIPPANY, N.J.--(BUSINESS WIRE)--Aug 31, 2023--

United-states , American , Bayer-kerendia , Robert-perkins , Semin-nephrol , Nikolaus-marx , Theresaa-mcdonagh , National-institutes-of-health , Bayer-healthcare-pharmaceuticals-inc , American-diabetes-association , Twitter , Heart-failure-association